Back
Aclaris Therapeutics Vs. Simulations Plus Industry Stock Comparison
Sell
40
ACRS
Aclaris Therapeutics
Last Price:
1.21
Seasonality Move:
-1.44%
Buy
55
SLP
Simulations Plus
Last Price:
38.85
Seasonality Move:
7.96%
Sell
40
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.20. The Score for ACRS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Simulations Plus (SLP)
is a Buy
Is Simulations Plus a Buy, Sell or Hold?
- The current Simulations Plus [SLP] share price is $38.89. The Score for SLP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- SLP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing slight buying pressure.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $38.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing selling pressure, which indicates risk of future bearish movement.
ACRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 55.65 | Buy |
Chaikin Money Flow: | 307365 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.05 - 1.19) | Buy |
Bollinger Bands (100): | (1.11 - 1.27) | Buy |
SLP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.23 | Sell |
Relative Strength Index (14 RSI): | 25.84 | Sell |
Chaikin Money Flow: | -135549 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.3 - 49.02) | Sell |
Bollinger Bands (100): | (42.23 - 48.59) | Sell |
ACRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Buy |
20-day SMA: | 1.14 | Buy |
50-day SMA: | 1.16 | Buy |
200-day SMA: | 2.02 | Sell |
8-day EMA: | 1.16 | Buy |
20-day EMA: | 1.15 | Buy |
50-day EMA: | 1.16 | Buy |
200-day EMA: | 2.7 | Sell |
SLP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.47 | Sell |
20-day SMA: | 46.57 | Sell |
50-day SMA: | 47.45 | Sell |
200-day SMA: | 42.53 | Sell |
8-day EMA: | 44.18 | Sell |
20-day EMA: | 46.04 | Sell |
50-day EMA: | 46.52 | Sell |
200-day EMA: | 44.33 | Sell |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.04 per share, an increase this year of $0.86 per share, and an increase next year of $0.23 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.11 per share, and an increase next year of $0.13 per share.
Aclaris Therapeutics Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Simulations Plus Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |